Aton Pharma, Inc.
Records under this name other than patents Aton Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,119,652 | Aryl-Fused Spirocyclic Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 7,795,304 | Histone Deacetylase Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 7,732,490 | Methods of Treating Cancer Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,119,685 | Disubstituted Aniline Compounds Formerly held In force · High confidence | In force | High confidence | |
| US 8,158,825 | Modified Malonate Derivatives Formerly held In force · High confidence | In force | High confidence | |
| US 9,452,974 | Stereoselective Synthesis of Metyrosine Formerly held In force · High confidence | In force | High confidence | |
| US 8,841,486 | Stereoselective Synthesis of Metyrosine Formerly held In force · High confidence | In force | High confidence | |
| US 11,730,697 | Ocular Drug Delivery Devices Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 7,772,238 | Benzothiophene Hydroxamic Acid Derivatives Formerly held Term ended Term ended Oct 23, 2026 · High confidence | Term ended | Term ended Oct 23, 2026 | High confidence |
| US 7,872,024 | Benzothiophene Hydroxamic Acid Derivatives with Carbamate, Urea, Amide and Sulfonamide Substitutions Formerly held Term ended Term ended Oct 23, 2026 · High confidence | Term ended | Term ended Oct 23, 2026 | High confidence |